Compare NNDM & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNDM | TKNO |
|---|---|---|
| Founded | 2012 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.1M | 268.1M |
| IPO Year | 2015 | 2021 |
| Metric | NNDM | TKNO |
|---|---|---|
| Price | $1.55 | $7.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 148.9K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,437,000.00 | $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 77.30 | 7.35 |
| 52 Week Low | $1.19 | $1.91 |
| 52 Week High | $2.32 | $7.84 |
| Indicator | NNDM | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 47.53 | 52.22 |
| Support Level | $1.50 | $4.87 |
| Resistance Level | $1.58 | $7.66 |
| Average True Range (ATR) | 0.05 | 0.36 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 33.33 | 43.51 |
Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.